Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma

By
Jamie Kang
-
0
9
Researchers performed preclinical studies to elucidate Dickkopf WNT Signaling Pathway Inhibitor 3 (DKK3)’s role in immune checkpoint inhibitors-resistant mouse mesothelioma.
[Clinical Cancer Research]
Abstract